NCT02509455 Balance Measures During Stance and Gait: Comparison of Gyroscopic Measurements of Trunk Sway
| NCT ID | NCT02509455 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Healthy |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2015-06 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2015-06 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate whether an extended version of Valedo®Motion (termed Sensoro for brand management purposes), has the same trunk sway measures similar normal reference values of SwayStar. Offline data analysis of data obtained from Sensoro will be compared to data obtained by SwayStar, a highly accurate and widely accepted system for measuring balance control.
Eligibility Criteria
Inclusion Criteria: * self reported lack of balance problems (checked by the ability to stand on 1 leg, eyes closed, for at least 14 secs). Exclusion Criteria: * orthopaedic problems * presence of diseases which cause balance problems.
Contact & Investigator
John HJ Allum, DSc
PRINCIPAL INVESTIGATOR
University Hospital, Basel, Switzerland
Frequently Asked Questions
Who can join the NCT02509455 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02509455 currently recruiting?
Yes, NCT02509455 is actively recruiting participants. Contact the research team at john.allum@usb.ch for enrollment information.
Where is the NCT02509455 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT02509455 clinical trial?
NCT02509455 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is John HJ Allum, DSc at University Hospital, Basel, Switzerland. The trial plans to enroll 300 participants.